143 related articles for article (PubMed ID: 36396095)
1. Opsoclonus-myoclonus syndrome: Clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort.
Cantarín-Extremera V; Jiménez-Legido M; Aguilera-Albesa S; Hedrera-Fernández A; Arrabal-Fernández L; Gorría-Redondo N; Martí-Carrera I; Yoldi-Pedtri ME; Sagaseta-De Ilúrdoz M; González-Gutiérrez-Solana L
Neurologia (Engl Ed); 2023 Mar; 38(2):93-105. PubMed ID: 36396095
[TBL] [Abstract][Full Text] [Related]
2. Opsoclonus-myoclonus syndrome: clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort.
Cantarín-Extremera V; Jiménez-Legido M; Aguilera-Albesa S; Hedrera-Fernández A; Arrabal-Fernández L; Gorría-Redondo N; Martí-Carrera I; Yoldi-Pedtri ME; Sagaseta-De Ilúrdoz M; González-Gutiérrez-Solana L
Neurologia (Engl Ed); 2020 Jul; ():. PubMed ID: 32653103
[TBL] [Abstract][Full Text] [Related]
3. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
4. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.
Hasegawa S; Matsushige T; Kajimoto M; Inoue H; Momonaka H; Oka M; Ohga S; Ichiyama T;
Brain Dev; 2015 Aug; 37(7):656-60. PubMed ID: 25454391
[TBL] [Abstract][Full Text] [Related]
5. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?
Galstyan A; Wilbur C; Selby K; Hukin J
Pediatr Neurol; 2017 Jul; 72():65-69. PubMed ID: 28479124
[TBL] [Abstract][Full Text] [Related]
6. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.
Rossor T; Yeh EA; Khakoo Y; Angelini P; Hemingway C; Irani SR; Schleiermacher G; Santosh P; Lotze T; Dale RC; Deiva K; Hero B; Klein A; de Alarcon P; Gorman MP; Mitchell WG; Lim M;
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260471
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
Koh PS; Raffensperger JG; Berry S; Larsen MB; Johnstone HS; Chou P; Luck SR; Hammer M; Cohn SL
J Pediatr; 1994 Nov; 125(5 Pt 1):712-6. PubMed ID: 7525913
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus-ataxia syndrome in children.
Bhatia P; Heim J; Cornejo P; Kane L; Santiago J; Kruer MC
J Neurol; 2022 Feb; 269(2):750-757. PubMed ID: 33779841
[TBL] [Abstract][Full Text] [Related]
10. Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED
Brain Dev; 2016 May; 38(5):439-48. PubMed ID: 26786246
[TBL] [Abstract][Full Text] [Related]
11. Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient.
Ghia T; Kanhangad M; Alessandri AJ; Price G; Gera P; Nagarajan L
Pediatr Neurol; 2016 Feb; 55():68-70. PubMed ID: 26778146
[TBL] [Abstract][Full Text] [Related]
12. Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
Aktekin EH; Gezer HÖ; Yazıcı N; Erol İ; Erbay A; Sarıalioğlu F
Neuropediatrics; 2024 Feb; 55(1):57-62. PubMed ID: 37019145
[TBL] [Abstract][Full Text] [Related]
13. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
[TBL] [Abstract][Full Text] [Related]
15. [Opsoclonus myoclonus ataxia syndrome in Israel].
Blumkin L; Lerman-Sagie T
Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
[TBL] [Abstract][Full Text] [Related]
16. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia.
Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I
Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus.
Pranzatelli MR; Slev PR; Tate ED; Travelstead AL; Colliver JA; Joseph SA
Pediatr Neurol; 2011 Jul; 45(1):27-33. PubMed ID: 21723456
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile and outcome of children with opsoclonus-myoclonus syndrome.
Singhi P; Sahu JK; Sarkar J; Bansal D
J Child Neurol; 2014 Jan; 29(1):58-61. PubMed ID: 23318697
[TBL] [Abstract][Full Text] [Related]
19. The opsoclonus–myoclonus syndrome.
Sahu JK; Prasad K
Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
[TBL] [Abstract][Full Text] [Related]
20. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
Blaes F; Dharmalingam B
Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
